The Asia-Pacific region (excluding Korea, China, Japan, India) has emerging biotechnology companies focused on developing treatments for neurodegenerative diseases. Singapore has positioned itself as a regional hub for biotech research, while Australia and New Zealand have active neuroscience research communities.
Singapore Companies
ES Revive Pte Ltd
ES Revive is a Singapore-based biotechnology company focused on developing treatments for age-related diseases, including neurodegenerative conditions.
Alterity Therapeutics is an Australian biotech company developing treatments for neurodegenerative diseases.
Headquarters: Melbourne, Victoria
Focus: Parkinson's disease, Huntington's disease
Key programs:
PBT434 - Novel small molecule
Status: Clinical trials
Actinogen Medical
Actinogen Medical is an Australian biotech focused on neurological disorders, developing treatments for Alzheimer's disease and major depressive disorder.
Recent Updates (2025-2026): An independent Data Monitoring Committee conducted a positive interim analysis and recommended the trial continue without amendment, citing unblinded safety and efficacy data supporting completion. The company secured funding beyond the trial results following a $16.8 million placement and share purchase plan, plus $7.4 million in FY2025 R&D tax incentives from the Australian Tax Office. Additional programs target cognitive impairment in major depressive disorder and behavioral symptoms in Fragile X Syndrome.
Neurotech Australia
Neurotech is an Australian company developing neurotechnology devices.
Headquarters: Brisbane, Queensland
Focus: Parkinson's disease, movement disorders
Approach: Deep brain stimulation technology
Status: Medical devices
SYNthesis Research
SYNthesis is an Australian contract research organization with neuroscience expertise.
Headquarters: Melbourne, Victoria
Focus: CNS drug development
Approach: Preclinical research services
Status: Research services
Taiwanese Companies
TaiRx Inc.
TaiRx is a Taiwanese biotech developing anti-aging and neuroprotective therapeutics.
Headquarters: Taipei, Taiwan
Focus: Alzheimer's disease, aging
Approach: Novel small molecules
Status: Research
Scinexxic
Scinexxic is a Taiwanese company focused on neurological disease therapeutics.
Headquarters: Taipei, Taiwan
Focus: Alzheimer's disease, Parkinson's disease
Approach: Protein aggregation inhibitors
Status: Preclinical
New Zealand Companies
NZ Neuro Research
NZ Neuro Research is a New Zealand company focused on neurological disease research.
Headquarters: Auckland
Focus: Neurodegeneration research
Approach: Academic partnerships
Status: Research
Cognitive Health Research NZ
Cognitive Health Research is focused on Alzheimer's disease research in New Zealand.
Headquarters: Wellington
Focus: Alzheimer's disease
Approach: Prevention strategies
Status: Research
Academic and Research Institutions
Singapore
Agency for Science, Technology and Research (A*STAR): Neuroscience research
National Neuroscience Institute (NNI): Clinical research
Duke-NUS Medical School: Neurodegeneration research
Australia
Florey Institute of Neuroscience and Mental Health: Alzheimer's research
Brain Institute (University of Queensland): Neurodegeneration
Monash University: CNS research
University of Sydney: Neuroscience research
Taiwan
Academia Sinica: Neuroscience research
National Taiwan University: Neurobiology research
Government Programs
Singapore
National Research Foundation: Biotech funding
EDB (Economic Development Board): Biotech incentives
Australia
National Health and Medical Research Council (NHMRC): Research funding
Medical Research Future Fund: Biomedical research
Clinical Trial Sites
Major pharmaceutical companies conduct clinical trials for neurodegenerative diseases at sites in: